3 Dividend Healthcare Stocks
The rapid aging of the world's population should ensure that demand for healthcare products and services remains on the rise for decades to come. But how can income investors take advantage of the trend? We posed that question to a team of healthcare investors and they suggested to check out AbbVie (NYSE: ABBV), Medtronic (NYSE: MDT), and ResMed (NYSE: RMD). Here's why.
Image source: Getty Images.
George Budwell (AbbVie): Despite being dealt a rather difficult hand after being spun off from its parent company Abbott Laboratories in 2013 due to the patent headwinds surrounding the megablockbuster anti-inflammatory medicine Humira, AbbVie has proven to be an outstanding dividend and growth stock. Since 2013, for example, AbbVie has produced industry-leading levels of revenue growth and has bumped up its dividend by a handsome 60% over the past four years. The net result is that AbbVie's shares have generated total shareholder returns in excess of 111% since inception.
Source: Fool.com
Medtronic plc Aktie
Einige Buy-Einschätzungen geben Medtronic plc den Vorteil gegenüber Sell-Einschätzungen.
Das Kursziel von 94 € für Medtronic plc weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 81.39 € hin.
